Medicare Enrolled
Dr. Jose Pulido, MD
Urology Physician · Paoli, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pulido from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pulido?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pulido
Dr. Jose Pulido is an urology physician in Paoli, PA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Pulido performed 10,634 Medicare services across 3,557 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pulido received a total of $11,318 from 43 pharmaceutical and/or device companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pulido is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 3% volume in PA
$11,318 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,634
Medicare services
Top 3% in PA for urology physician
3,557
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~886 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 6,025 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,044 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
565 | $98 | $294 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
541 | $67 | $199 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
517 | $9 | $112 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
282 | $50 | $137 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 164 | $138 | $839 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
125 | $72 | $260 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
112 | $66 | $415 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
104 | $126 | $385 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
103 | $4 | $17 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
102 | $10 | $178 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $45 | $133 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
80 | $0 | $16 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
66 | $106 | $611 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
59 | $3 | $9 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
57 | $3 | $23 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
49 | $26 | $433 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
47 | $62 | $255 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
47 | $29 | $104 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $100 | $304 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
36 | $40 | $101 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
35 | $50 | $180 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $85 | $276 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
32 | $8 | $12 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
27 | $338 | $1,331 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $142 | $392 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
27 | $231 | $311 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $66 | $163 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $12 | $78 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
23 | $167 | $535 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
23 | $30 | $169 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
22 | $27 | $451 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
21 | $323 | $927 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
17 | $126 | $578 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
15 | $70 | $214 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
12 | $2,525 | $7,479 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
12 | $49 | $1,045 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
7.8% medium
91.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,318
Total received (2018-2024)
Avg $1,617/year across 7 years
Top 13% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
240
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,244 (55.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,953 (43.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$121 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,605
2023
$1,317
2022
$613
2021
$729
2020
$600
2019
$1,347
2018
$107
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$3,584
Janssen Biotech, Inc.
$1,369
PROCEPT BioRobotics Corporation
$293
Dendreon Pharmaceuticals LLC
$216
Bayer Healthcare Pharmaceuticals Inc.
$165
Medtronic, Inc.
$150
ABBVIE INC.
$139
Antares Pharma, Inc.
$114
Sumitomo Pharma America, Inc.
$106
Tolmar, Inc.
$98
Astellas Pharma US Inc
$92
Boston Scientific Corporation
$62
PFIZER INC.
$34
Teleflex LLC
$32
Merck Sharp & Dohme LLC
$22
Ferring Pharmaceuticals Inc.
$21
Novartis Pharmaceuticals Corporation
$21
AstraZeneca Pharmaceuticals LP
$20
Axonics, Inc.
$19
IMMUNITYBIO, INC.
$18
Telix Pharmaceuticals
$16
Myriad Genetic Laboratories, Inc.
$14
Top 3 companies account for 79.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$3,584
Janssen Biotech, Inc.
$1,702
Dendreon Pharmaceuticals LLC
$918
Astellas Pharma US Inc
$880
PROCEPT BioRobotics Corporation
$448
Medtronic, Inc.
$340
Medtronic USA, Inc.
$340
Boston Scientific Corporation
$327
PFIZER INC.
$296
Antares Pharma, Inc.
$217
Bayer Healthcare Pharmaceuticals Inc.
$203
ABBVIE INC.
$168
Amgen Inc.
$158
Merck Sharp & Dohme LLC
$149
Ferring Pharmaceuticals Inc.
$147
Tolmar, Inc.
$139
Sumitomo Pharma America, Inc.
$127
Bayer HealthCare Pharmaceuticals Inc.
$114
BOSTON SCIENTIFIC CORPORATION
$107
NeoTract Inc.
$94
Myriad Genetic Laboratories, Inc.
$81
Teleflex LLC
$76
BAXTER HEALTHCARE
$76
AstraZeneca Pharmaceuticals LP
$76
ConvaTec Inc.
$72
Axonics, Inc.
$48
Progenics Pharmaceuticals, Inc.
$47
Supernus Pharmaceuticals, Inc.
$46
Novartis Pharmaceuticals Corporation
$46
AbbVie Inc.
$39
Merck Sharp & Dohme Corporation
$35
UroGen Pharma, Inc.
$24
UROVANT SCIENCES INC
$24
GENZYME CORPORATION
$23
Acerus Pharmaceuticals Corporation
$20
Clarus Therapeutics Inc.
$18
IMMUNITYBIO, INC.
$18
Telix Pharmaceuticals
$16
ACCORD HEALTHCARE, INC.
$16
Myovant Sciences Inc.
$16
Sun Pharmaceutical Industries Inc.
$14
180 Medical, Inc.
$14
Coloplast Corp
$12
Top 3 companies account for 54.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AMS 700 · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axonics · BALVERSA · BOTOX · BRACANALYSIS CDX · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLOSEAL · GEMTESA · GENERAL UTERINE TISSUE REMOVAL · GENERAL - UTERINE TISSUE REMOVAL · GENTLECATH · ILLUCCIX · INTERSTIM · JATENZO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · Otrexup · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolia · Rezum Generator · SpaceOAR System · SpeediCath · TLANDO · UROLIFT · UroLift · UroLift System · XGEVA · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (55%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
255
Per 100K population
47.1
County median income
$123,041
Nearest hospital
PAOLI HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pulido is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with low-engagement industry engagement in the top 13% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pulido experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Pulido performed 6,025 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pulido receive payments from pharmaceutical companies?
Yes. Dr. Pulido received a total of $11,318 from 43 companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pulido's costs compare to other urology physicians in Paoli?
Dr. Pulido's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pulido) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Paoli
Browse urology physicians in Paoli ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology